StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.34−0.64 (-3.37%)

Close on Nov 19, 2026Market cap $881.39MP/E –Yield –

Odyssey Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Odyssey Therapeutics's shares outstanding was 30M at Jun 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202630M–
Q1 FY2026Mar 31, 20266M–
Q2 FY2025Jun 30, 20251M–
Q1 FY2025Mar 31, 20251M–

More Odyssey Therapeutics figures

See a number that looks wrong?